Executive Team
Board of Directors
Scientific and Clinical Advisory Board
Key People
Mission Statement
Research and Development
PI3K
PTEN
Product Pipeline
Clinical Trials
News
Events: Upcoming and Past
Contact Us
Investor Relations
For more information please contact: Sandi Yurichuk, Chief Business Officer, at (650) 576-5769.
© Semafore Pharmaceuticals Inc.